These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33255172)

  • 1. Antibacterial and Anti-Inflammatory Activity of an Antimicrobial Peptide Synthesized with D Amino Acids.
    Brunetti J; Carnicelli V; Ponzi A; Di Giulio A; Lizzi AR; Cristiano L; Cresti L; Cappello G; Pollini S; Mosconi L; Rossolini GM; Bracci L; Falciani C; Pini A
    Antibiotics (Basel); 2020 Nov; 9(12):. PubMed ID: 33255172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Peptides Active in In Vitro Models of Endodontic Bacterial Infections Modulate Inflammation in Human Cardiac Fibroblasts.
    Marianantoni G; Meogrossi G; Tollapi E; Rencinai A; Brunetti J; Marruganti C; Gaeta C; Pini A; Bracci L; Ferrari M; Grandini S; Falciani C
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens.
    Falciani C; Lozzi L; Pollini S; Luca V; Carnicelli V; Brunetti J; Lelli B; Bindi S; Scali S; Di Giulio A; Rossolini GM; Mangoni ML; Bracci L; Pini A
    PLoS One; 2012; 7(10):e46259. PubMed ID: 23056272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.
    Pini A; Falciani C; Mantengoli E; Bindi S; Brunetti J; Iozzi S; Rossolini GM; Bracci L
    FASEB J; 2010 Apr; 24(4):1015-22. PubMed ID: 19917670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.
    Chu WC; Bai PY; Yang ZQ; Cui DY; Hua YG; Yang Y; Yang QQ; Zhang E; Qin S
    Eur J Med Chem; 2018 Jan; 143():905-921. PubMed ID: 29227931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anti-lipopolysaccharide factor SpALF6 in mud crab Scylla paramamosain exhibiting different antimicrobial activity from its single amino acid mutant.
    Hou ZG; Wang Y; Hui K; Fang WH; Zhao S; Zhang JX; Ma H; Li XC
    Dev Comp Immunol; 2017 Jul; 72():44-56. PubMed ID: 28232132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial Small Molecules That Potently Inhibit Staphylococcus aureus Lipoteichoic Acid Biosynthesis.
    Naclerio GA; Karanja CW; Opoku-Temeng C; Sintim HO
    ChemMedChem; 2019 May; 14(10):1000-1004. PubMed ID: 30939229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides.
    Warshakoon HJ; Burns MR; David SA
    Antimicrob Agents Chemother; 2009 Jan; 53(1):57-62. PubMed ID: 18955537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue.
    Quercini L; Brunetti J; Riolo G; Bindi S; Scali S; Lampronti I; D'Aversa E; Wronski S; Pollini S; Gentile M; Lupetti P; Rossolini GM; Falciani C; Bracci L; Pini A
    FASEB J; 2020 Jan; 34(1):192-207. PubMed ID: 31914681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):1-21. PubMed ID: 11977919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
    Hussein M; Karas JA; Schneider-Futschik EK; Chen F; Swarbrick J; Paulin OKA; Hoyer D; Baker M; Zhu Y; Li J; Velkov T
    mSystems; 2020 May; 5(3):. PubMed ID: 32457238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of E-101 Solution, a novel myeloperoxidase-mediated antimicrobial, against Gram-positive and Gram-negative pathogens.
    Denys GA; Grover P; O'Hanley P; Stephens JT
    J Antimicrob Chemother; 2011 Feb; 66(2):335-42. PubMed ID: 21118915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2.
    Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC
    Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A D-enantiomer of the antimicrobial peptide GL13K evades antimicrobial resistance in the Gram positive bacteria Enterococcus faecalis and Streptococcus gordonii.
    Hirt H; Hall JW; Larson E; Gorr SU
    PLoS One; 2018; 13(3):e0194900. PubMed ID: 29566082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cysteine-free venom peptide with strong antimicrobial activity against antibiotics-resistant pathogens from the scorpion Opistophthalmus glabrifrons.
    Bao A; Zhong J; Zeng XC; Nie Y; Zhang L; Peng ZF
    J Pept Sci; 2015 Oct; 21(10):758-64. PubMed ID: 26251012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.